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Abstract—The goal of the plenary talk is to give an overview 
on the one of the most dynamically changing research topic: 
cyber-medical systems. 
 
By the needs of Industry 4.0 digitalization of industry 
has been accentuated. However, cybersphysical systems 
left its footprints in healthcare as well, formalizing the 
cyber-medical system requirements: how to help everyday 
life of medical doctors and patients by using medical 
devices in a more personalized way. 
This concept meshes the entire biomedical engineering 
research field. The idea is to create mathematical 
algorithms able to be personalized on the patients’ need 
and physiology, use cloud computation techniques to 
fasten the decision support and big data analysis for 
feature extraction. As a result, the cyber-medical system 
concept is equivalent with a smart healthcare framework 
where by using the computational power possibilities 
together with machine learning, artificial intelligence and 
control engineering methods we would like to intensify 
the decision support of doctors, nurses and patients in 
order to use in an intelligent way the knowledge-based 
medical applications. 
The presentation will give an overview on the above 
mentioned aspects: how the cyber-medical system concept 
appeared, what the trends are, how it is influencing our 
everyday’s life including education, research, medical 
industry and healthcare sector. In order to give concrete 
examples, individualized model-based applications are 
presented such as: 
• Artificial pancreas problem: Recent 
technological advances in diabetes treatment like 
Continuous Glucose Monitors (CGMs) for the 
subcutaneous measurement of glucose concentration and 
insulin pumps for the subcutaneous delivery of insulin 
allowed investigating the applicability of an external 
controller. In type 1 diabetes, where the disease can be 
characterized as a general clinical picture (e.g. complete 
pancreatic β-cell insufficiency) different individualized 
model-based (mostly model predictive control (MPC) 
based) solutions have been already formulated and even 
clinical trials appeared demonstrating its applicability. 
However, closing the loop needs the integration of 
individualized control methods and robust control 
algorithms in order to successfully reject hypoglycemic 
episodes. Moreover, the scientific community started to 
transpose the problem on type 2 diabetes as well, trying to 
cover the largest diabetic population with the artificial 
pancreas concept. 
• Tamed cancer concept: Beside general cancer 
therapies like chemotherapy, targeted molecular therapies 
appeared in order to focus on a given mechanism of the 
tumor growth stopping it in a more effective / 
individualized way. Antiangiogenic therapy is one 
targeted molecular therapy arose in the last decade which 
aims to stop tumor angiogenesis, i.e. formation of new 
blood vessels; hence, minimizing the tumor’s volume. 
However, the corresponding drugs are very expensive, and 
in high doses may have side effects; moreover, the 
currently used clinical protocols are determined 
empirically. As a consequence, this problem can be seen 
as a double optimal control problem: on the one hand the 
aim is to minimize the tumor’s volume by a model-based 
control algorithm, but it is also crucial to inject the 
corresponding inhibitor (drug) in an optimal way 
(minimizing costs). Due to the heterogeneous nature of the 
patients by a recently gained ERC StG grant of the 
European Union we try to develop a novel concept: 
taming cancer. Beside creating a more realistic tumor 
growth mathematical model, we would like to decrease 
the injection sampling time of inhibitors that combined 
with a robust control method can control the tumor 
volume artificially and in this taming it. As a result it 
would be even possible living with the tumor in a 
controlled way. 
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